Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.

Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP.

Am J Gastroenterol. 2018 Nov 8. doi: 10.1038/s41395-018-0383-2. [Epub ahead of print]

PMID:
30410039
2.

Risk factors for recurrent percutaneous nephrostomy catheter-related infections.

Szvalb AD, El Haddad H, Rolston KV, Sabir SH, Jiang Y, Raad II, Viola GM.

Infection. 2018 Nov 7. doi: 10.1007/s15010-018-1245-y. [Epub ahead of print]

PMID:
30406481
3.

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy.

Wilson Dib R, Chaftari AM, Hachem RY, Yuan Y, Dandachi D, Raad II.

Open Forum Infect Dis. 2018 Oct 1;5(10):ofy249. doi: 10.1093/ofid/ofy249. eCollection 2018 Oct.

4.

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania.

Raad II, Chaftari AM, Torres HA, Ayoub EM, Narouz LI, Bartek J, Hachem R.

World J Hepatol. 2018 Sep 27;10(9):549-557. doi: 10.4254/wjh.v10.i9.549. Review.

5.

Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East.

Raad II, Chaftari AM, Dib RW, Graviss EA, Hachem R.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1230-1236. doi: 10.1017/ice.2018.177. Epub 2018 Aug 13.

PMID:
30099975
6.

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections.

Hachem R, Kanj S, Hamerschlak N, Saad H, Assir FF, Mori N, Jiang Y, Ghaly F, Chaftari AM, Raad II.

Expert Rev Med Devices. 2018 Jun;15(6):461-466. doi: 10.1080/17434440.2018.1483237.

PMID:
29927699
7.

Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer.

El Haddad H, Chaftari AM, Hachem R, Chaftari P, Raad II.

Clin Infect Dis. 2018 Aug 31;67(6):971-977. doi: 10.1093/cid/ciy331.

PMID:
29668936
8.

In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.

Rolston KVI, Reitzel R, Vargas-Cruz N, Shelburne SA, Raad II, Prince RA.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):351-353. doi: 10.1016/j.diagmicrobio.2018.03.009. Epub 2018 Mar 16.

PMID:
29661529
9.

Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia.

Rosenblatt J, Reitzel RA, Vargas-Cruz N, Chaftari AM, Hachem R, Raad II.

J Fungi (Basel). 2017 Feb 10;3(1). pii: E7. doi: 10.3390/jof3010007.

10.

Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.

Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, Chaftari AM, Raad II.

Int J Antimicrob Agents. 2017 Sep;50(3):384-388. doi: 10.1016/j.ijantimicag.2017.03.021. Epub 2017 Jul 8.

PMID:
28694233
11.

Novel plasma telomerase detection method to improve cancer diagnostic assessment.

Hilal G, Reitzel R, Al Hamal Z, Chaftari AM, Al Wohoush I, Jiang Y, Hachem R, Raad II.

PLoS One. 2017 May 3;12(5):e0174266. doi: 10.1371/journal.pone.0174266. eCollection 2017.

12.

Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies.

Zakhour R, Chaftari AM, Raad II.

Lancet Infect Dis. 2016 Nov;16(11):e241-e250. doi: 10.1016/S1473-3099(16)30213-4. Review.

PMID:
27788992
13.

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center.

Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II.

J Natl Compr Canc Netw. 2016 Sep;14(9):1185-8. No abstract available.

PMID:
27587628
14.

Improving Antimicrobial Regimens for the Treatment of Breast Tissue Expander-Related Infections.

Viola GM, Baumann DP, Mohan K, Selber J, Garvey P, Reece G, Raad II, Rolston KV, Crosby MA.

Plast Reconstr Surg Glob Open. 2016 May 6;4(5):e704. doi: 10.1097/GOX.0000000000000690. eCollection 2016 May.

15.

Drug eluting antimicrobial vascular catheters: Progress and promise.

Viola GM, Rosenblatt J, Raad II.

Adv Drug Deliv Rev. 2017 Mar;112:35-47. doi: 10.1016/j.addr.2016.07.011. Epub 2016 Aug 2. Review.

PMID:
27496702
16.

Salvaging the Infected Breast Tissue Expander: A Standardized Multidisciplinary Approach.

Viola GM, Selber JC, Crosby M, Raad II, Butler CE, Villa MT, Kronowitz SJ, Clemens MW, Garvey P, Yang W, Baumann DP.

Plast Reconstr Surg Glob Open. 2016 Jun 10;4(6):e732. doi: 10.1097/GOX.0000000000000676. eCollection 2016 Jun.

17.

Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism.

Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari AM, Raad II.

Medicine (Baltimore). 2016 Apr;95(14):e2691. doi: 10.1097/MD.0000000000002691.

18.

Glyceryl trinitrate and caprylic acid for the mitigation of the Desulfovibrio vulgaris biofilm on C1018 carbon steel.

Li Y, Zhang P, Cai W, Rosenblatt JS, Raad II, Xu D, Gu T.

World J Microbiol Biotechnol. 2016 Feb;32(2):23. doi: 10.1007/s11274-015-1968-1. Epub 2016 Jan 8.

PMID:
26745983
19.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
20.

Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting.

Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1461-3. doi: 10.1017/ice.2015.208. Epub 2015 Sep 2.

PMID:
26329908
21.

Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.

Jamal MA, Garoge K, Rosenblatt JS, Hachem RY, Raad II.

Antimicrob Agents Chemother. 2015 Aug;59(8):4397-402. doi: 10.1128/AAC.04956-14. Epub 2015 May 4.

22.

Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms.

Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF.

J Med Microbiol. 2015 Feb;64(Pt 2):191-4. doi: 10.1099/jmm.0.000004-0. Erratum in: J Med Microbiol. 2015 May;64(Pt 5):586.

23.

Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.

Torres HA, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP.

J Natl Compr Canc Netw. 2015 Jan;13(1):41-50.

PMID:
25583768
24.

Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.

Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R.

Int J Antimicrob Agents. 2015 Mar;45(3):283-8. doi: 10.1016/j.ijantimicag.2014.08.012. Epub 2014 Oct 12.

PMID:
25455847
25.

Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.

Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, Ramos E, Jiang Y, Chaftari AM, Raad II.

J Antimicrob Chemother. 2014 Nov;69(11):3148-55. doi: 10.1093/jac/dku241. Epub 2014 Jul 8.

PMID:
25006241
26.

Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.

Jamal MA, Rosenblatt J, Jiang Y, Hachem R, Chaftari AM, Raad II.

Antimicrob Agents Chemother. 2014 Sep;58(9):5291-6. doi: 10.1128/AAC.02886-14. Epub 2014 Jun 23.

27.

Ommaya reservoir-related infections: clinical manifestations and treatment outcomes.

Szvalb AD, Raad II, Weinberg JS, Suki D, Mayer R, Viola GM.

J Infect. 2014 Mar;68(3):216-24. doi: 10.1016/j.jinf.2013.12.002. Epub 2013 Dec 17.

PMID:
24360921
28.

Breast tissue expander-related infections: perioperative antimicrobial regimens.

Viola GM, Raad II, Rolston KV.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):75-81. doi: 10.1086/674390. Epub 2013 Nov 26.

PMID:
24334802
29.

Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.

Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II.

Antimicrob Agents Chemother. 2014;58(2):1179-82. doi: 10.1128/AAC.01959-13. Epub 2013 Oct 28.

30.

Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms.

Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II.

Antimicrob Agents Chemother. 2013 Aug;57(8):3555-60. doi: 10.1128/AAC.00229-13. Epub 2013 May 13.

31.

Comparison of bacterial adherence to titanium versus polyurethane for cardiac implantable electronic devices.

Viola GM, Rosenblatt J, Raad II, Darouiche RO.

Am J Cardiol. 2013 Jun 15;111(12):1764-6. doi: 10.1016/j.amjcard.2013.02.035. Epub 2013 Mar 20.

PMID:
23523061
32.

Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications.

Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY.

Ann Oncol. 2013 Jul;24(7):1873-9. doi: 10.1093/annonc/mdt110. Epub 2013 Mar 21.

33.

Rapidly growing mycobacterial bloodstream infections.

El Helou G, Viola GM, Hachem R, Han XY, Raad II.

Lancet Infect Dis. 2013 Feb;13(2):166-74. doi: 10.1016/S1473-3099(12)70316-X. Review.

PMID:
23347634
34.

Management of rapidly growing mycobacterial bacteremia in cancer patients.

El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, Tarrand J, Raad II.

Clin Infect Dis. 2013 Mar;56(6):843-6. doi: 10.1093/cid/cis1032. Epub 2012 Dec 19.

PMID:
23254418
35.

Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment.

Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DP.

Microb Pathog. 2013 Feb;55:16-20. doi: 10.1016/j.micpath.2012.11.012. Epub 2012 Dec 8.

PMID:
23232438
36.

Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors.

Bahu R, Chaftari AM, Hachem RY, Ahrar K, Shomali W, El Zakhem A, Jiang Y, AlShuaibi M, Raad II.

J Urol. 2013 Jan;189(1):130-5. doi: 10.1016/j.juro.2012.08.094. Epub 2012 Nov 16.

PMID:
23164390
37.

An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection.

Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE.

J Infect Dis. 2012 Nov;206(9):1367-71. doi: 10.1093/infdis/jis516. Epub 2012 Aug 22.

38.

Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.

Chaftari AM, Hachem RY, Ramos E, Kassis C, Campo M, Jiang Y, Prince RA, Wang W, Raad II.

Transplantation. 2012 Aug 15;94(3):302-8. doi: 10.1097/TP.0b013e3182577485.

PMID:
22814329
39.

Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center.

Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF.

Oncologist. 2012;17(10):1329-36. doi: 10.1634/theoncologist.2012-0029. Epub 2012 Jun 15.

40.

Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study.

Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II.

J Clin Virol. 2012 Jul;54(3):218-22. doi: 10.1016/j.jcv.2012.03.002. Epub 2012 Mar 28.

PMID:
22459004
41.

A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes.

Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II.

Cancer. 2012 Sep 15;118(18):4627-33. doi: 10.1002/cncr.27447. Epub 2012 Feb 22.

42.

Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way.

Torres HA, Adachi JA, Roach LR, Smith KM, Mahale PS, Davila M, Raad II.

Clin Infect Dis. 2012 Mar 1;54(5):740-2. doi: 10.1093/cid/cir930. No abstract available.

43.

Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer.

Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF.

Pediatr Infect Dis J. 2012 Apr;31(4):373-8. doi: 10.1097/INF.0b013e3182481ef8.

PMID:
22228234
44.

Hospital environment and invasive aspergillosis in patients with hematologic malignancy.

Lee LD, Hachem RY, Berkheiser M, Hackett B, Jiang Y, Raad II.

Am J Infect Control. 2012 Apr;40(3):247-9. doi: 10.1016/j.ajic.2011.03.031.

PMID:
21856045
45.

Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients.

Chaftari AM, Kassis C, El Issa H, Al Wohoush I, Jiang Y, Rangaraj G, Caillouet B, Pravinkumar SE, Hachem RY, Raad II.

Cancer. 2011 Jun 1;117(11):2551-8. doi: 10.1002/cncr.25807. Epub 2010 Dec 14.

46.

Guidelines for the prevention of intravascular catheter-related infections.

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee.

Am J Infect Control. 2011 May;39(4 Suppl 1):S1-34. doi: 10.1016/j.ajic.2011.01.003. No abstract available.

PMID:
21511081
47.

Clinical experience of linezolid in bone marrow transplantation patients.

Hogan HL, Hachem RY, Neuhauser M, Raad II, Coyle E.

J Pharm Pract. 2010 Aug;23(4):352-7. doi: 10.1177/0897190009358773. Epub 2010 Mar 31.

PMID:
21507835
48.

Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1).

Clin Infect Dis. 2011 May;52(9):1087-99. doi: 10.1093/cid/cir138. No abstract available.

49.

Guidelines for the prevention of intravascular catheter-related infections.

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee (HICPAC).

Clin Infect Dis. 2011 May;52(9):e162-93. doi: 10.1093/cid/cir257. Epub 2011 Apr 1. No abstract available.

50.

The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes.

Raad II, Mohamed JA, Reitzel RA, Jiang Y, Dvorak TL, Ghannoum MA, Hachem RY, Chaftari AM.

Biomaterials. 2011 Apr;32(11):2689-94. doi: 10.1016/j.biomaterials.2010.12.015. Epub 2011 Feb 3.

PMID:
21295343

Supplemental Content

Support Center